PHS
GILD icon

Pekin Hardy Strauss’s Gilead Sciences GILD Stock Holding History

Pekin Hardy Strauss’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,000
Closed -$72K – 190
2017
Q4 		$72K Hold
1,000
– – 0.01% 183
2017
Q3 		$82K Hold
1,000
– – 0.02% 186
2017
Q2 		$70K Hold
1,000
– – 0.01% 183
2017
Q1 		$68K Buy
+1,000
New +$70.3K 0.01% 175

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pekin Hardy Strauss's GILD Position: Q1 2026 in Review

Pekin Hardy Strauss reduced its Gilead Sciences (GILD) stake by 1.6% in Q1 2026, selling an estimated $9.1K and leaving 3,908 shares worth $545K. The position accounts for 0.06% of the portfolio, ranked #291.

Pekin Hardy Strauss first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.48M in Q1 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Pekin Hardy Strauss held 3,908 shares of Gilead Sciences worth $545K as of Q1 2026.
  • Pekin Hardy Strauss sold 65 Gilead Sciences shares in Q1 2026, an estimated $9.1K.
  • Gilead Sciences made up 0.06% of Pekin Hardy Strauss's portfolio in Q1 2026, its #291 holding.
  • Pekin Hardy Strauss first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Pekin Hardy Strauss's Gilead Sciences position peaked at $1.48M in Q1 2020.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pekin Hardy Strauss's 13F filing for Q1 2026, filed 7 May 2026.